Abstract:Background miRNAs are a group of small RNA molecules regulating target genes by inducing mRNA degradation or translational repression. Aberrant expression of miRNAs correlates with various cancers. Although miR-135a has been implicated in several other cancers, its role in breast cancer is unknown. HOXA10 however, is associated with multiple cancer types and was recently shown to induce p53 expression in breast cancer cells and reduce their invasive ability. Because HOXA10 is a confirmed miR-135a target in more than one tissue, we examined miR-135a levels in relation to breast cancer phenotypes to determine if miR-135a plays role in this cancer type. Methods Expression levels of miR-135a in tissues and cells were determined by poly (A)-RT PCR. The effect of miR-135a on proliferation was evaluated by CCK8 assay, cell migration and invasion were evaluated by transwell migration and invasion assays, and target protein expression was determined by western blotting. GFP and luciferase reporter plasmids were constructed to confirm the action of miR-135a on downstream target genes including HOXA10 . Results are reported as means ± S.D. and differences were tested for significance using 2-sided Student"s t-test. Results Here we report that miR-135a was highly expressed in metastatic breast tumors. We found that the expression of miR-135a was required for the migration and invasion of breast cancer cells, but not their proliferation. HOXA10 , which encodes a transcription factor required for embryonic development and is a metastasis suppressor in breast cancer, was shown to be a direct target of miR-135a in breast cancer cells. Our analysis showed that miR-135a suppressed the expression of HOXA10 both at the mRNA and protein level, and its ability to promote cellular migration and invasion was partially reversed by overexpression of HOXA10 . Conclusions In summary, our results indicate that miR-135a is an onco-miRNA that can promote breast cancer cell migration and invasion. HOXA10 is a target gene for miR-135a in breast cancer cells and overexpression of HOXA10 can partially reverse the miR-135a invasive phenotype.

MiR-135a Functions As a Tumor Suppressor in Epithelial Ovarian Cancer and Regulates HOXA10 Expression.

Mir-215 Functions As a Tumor Suppressor in Epithelial Ovarian Cancer Through Regulation of the X-chromosome-linked Inhibitor of Apoptosis.

Inhibition Of Ovarian Epithelial Carcinoma Tumorigenesis And Progression By Microrna 106b Mediated Through The Rhoc Pathway

Role of Microrna-133A in Epithelial Ovarian Cancer Pathogenesis and Progression.

MiR-5195-3p functions as a tumor suppressor by targeting RHBDD1 in ovarian cancer

Microrna-150 Predicts A Favorable Prognosis In Patients With Epithelial Ovarian Cancer, And Inhibits Cell Invasion And Metastasis By Suppressing Transcriptional Repressor Zeb1

MicroRNA‑665 Suppresses the Growth and Migration of Ovarian Cancer Cells by Targeting HOXA10

Tumor-suppressor Role of Mir-139-5p in Endometrial Cancer

Downregulation of Hsa_circ_0026123 Suppresses Ovarian Cancer Cell Metastasis and Proliferation Through the Mir‑124‑3p/ezh2 Signaling Pathway.

Mirna-135A Promotes Breast Cancer Cell Migration and Invasion by Targeting HOXA10

MicroRNA-219-5p Inhibits the Proliferation, Migration, and Invasion of Epithelial Ovarian Cancer Cells by Targeting the Twist/Wnt/β-catenin Signaling Pathway.

Microrna-137 Promotes Apoptosis in Ovarian Cancer Cells Via the Regulation of Xiap

Mir-494 Suppresses Tumor Growth of Epithelial Ovarian Carcinoma by Targeting IGF1R

MicroRNA-184 Acts As a Potential Diagnostic and Prognostic Marker in Epithelial Ovarian Cancer and Regulates Cell Proliferation, Apoptosis and Inflammation.

miR-99a promotes proliferation targeting FGFR3 in human epithelial ovarian cancer cells.

Microrna-130b Functions As A Tumor Suppressor by Regulating Runx3 in Epithelial Ovarian Cancer

MiR-596 activated by EP300 controls the tumorigenesis in epithelial ovarian cancer by declining BRD4 and KPNA4

MicroRNA-216a Promotes the Metastasis and Epithelial-Mesenchymal Transition of Ovarian Cancer by Suppressing the PTEN/AKT Pathway.

Mir-132 Targeting E2F5 Suppresses Cell Proliferation, Invasion, Migration in Ovarian Cancer Cells.

MiR-221-3p targets ARF4 and inhibits the proliferation and migration of epithelial ovarian cancer cells

Mir-532-5p is a Prognostic Marker and Suppresses Cells Proliferation and Invasion by Targeting TWIST1 in Epithelial Ovarian Cancer.